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HIGHLIGHTS
• Computational techniques provide accurate descriptions of the structure and
dynamics of biological systems, contributing to their understanding at an atomic level.
• Classical MD simulations are a precious computational tool for the processes where
no chemical reactions take place.
• QM calculations provide valuable information about the enzyme activity, being able to
distinguish among several mechanistic pathways, provided a carefully selected cluster
model of the enzyme is considered.
• Multiscale QM/MM simulation is the method of choice for the computational treatment
of enzyme reactions offering quantitative agreement with experimentally determined
reaction parameters.
• Molecular simulation provide insight into the mechanism of both the catalytic activity
and inhibition of monoamine oxidases, thus aiding in the rational design of their
inhibitors that are all employed and antidepressants and antiparkinsonian drugs.
Aging society and therewith associated neurodegenerative and neuropsychiatric
diseases, including depression, Alzheimer’s disease, obsessive disorders, and
Parkinson’s disease, urgently require novel drug candidates. Targets include monoamine
oxidases A and B (MAOs), acetylcholinesterase (AChE), butyrylcholinesterase (BChE),
and various receptors and transporters. For rational drug design it is particularly
important to combine experimental synthetic, kinetic, toxicological, and pharmacological
information with structural and computational work. This paper describes the application
of various modern computational biochemistry methods in order to improve the
understanding of a relationship between the structure and function of large biological
systems including ion channels, transporters, receptors, and metabolic enzymes. The
methods covered stem from classical molecular dynamics simulations to understand
the physical basis and the time evolution of the structures, to combined QM, and
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QM/MM approaches to probe the chemical mechanisms of enzymatic activities and their
inhibition. As an illustrative example, the later will focus on the monoamine oxidase family
of enzymes, which catalyze the degradation of amine neurotransmitters in various parts
of the brain, the imbalance of which is associated with the development and progression
of a range of neurodegenerative disorders. Inhibitors that act mainly on MAO A are used
in the treatment of depression, due to their ability to raise serotonin concentrations, while
MAO B inhibitors decrease dopamine degradation and improve motor control in patients
with Parkinson disease. Our results give strong support that bothMAO isoforms, A and B,
operate through the hydride transfer mechanism. Relevance of MAO catalyzed reactions
and MAO inhibition in the context of neurodegeneration will be discussed.
Keywords: computational enzymology, molecular dynamics simulation, central nervous system, neural signal
transduction, drug design, hydride transfer reaction, neurotransmitter metabolism, multiscale simulations
INTRODUCTION
Neurodegenerative disorder, such as Alzheimer’s disease,
Parkinson’s disease, and Huntington’s disease, is an umbrella
term for a range of incurable and debilitating conditions which
primarily affect the neurons in the human brain and result in
their progressive degeneration and/or death, causing problems
with movement (ataxias) or mental functioning (dementias).
Although perceived as the diseases of the elderly, these disorders
can have a much earlier onset, starting even before the age of 40,
leading to long-term treatment and substantial financial burden
for the public healthcare systems. Two recent landmark reports
(Gustavsson et al., 2011; Wittchen et al., 2011), conducted within
EU–27 countries plus three allied countries (Norway, Iceland,
Switzerland), providing the most complete picture ever of these
disorders in Europe, estimated that the societal burden of brain
disorders is immense: over 160 million people are affected, more
than 36% of the total population, while the costs are equally
disturbing amounting to a total of €798 billion per year in
2010—one third of all health related expenses—higher than for
heart diseases, cancer, and diabetes combined. A breakdown
of the nature of the costs shows that just over one third are
direct healthcare costs, a quarter direct non-medical costs
and the remaining 40% indirect costs associated with loss of
productivity. In spite of this, there is at present no effective
treatment able to slow down or stop the deterioration of brain
Abbreviations: MAO, monoamine oxidase; GPCR, G-protein coupled receptors;
QM, quantum mechanics; MM, molecular mechanics; MD, molecular dynamics;
QM/MM, quantum mechanical/molecular mechanical; EVB, empirical valence
bond; VB, valence bond; AChE, acetylcholinesterase; BChE, butyrylcholinesterase;
WT, wild type; QCP, quantum classical path; KIE, kinetic isotope effect; DFT,
density functional theory; FEP, free-energy perturbation; US, umbrella sampling;
CCM, cholesterol consensus motif; CRAC, cholesterol recognition/interaction
amino acid; TRP, transient receptor potential; FAD, flavin adenine dinucleotide;
RMSD, root-mean-square deviation; PDLP/S–LRA, semimacroscopic protein
dipole/Langevin dipole approach in its linear response approximation version;
DAAO, D–amino acid oxidases; TMO, tryptophan-2-monooxygenase; MTOX, N-
methyltryptophan oxidase; CPCM, conductor-like polarizable continuum model;
NBO, natural bond orbitals; SCAAS, surface-constrained all atom solvent model;
FEP/US, free energy perturbation/umbrella sampling; IRC, intrinsic reaction
coordinate; ROS, reactive oxygen species; αSyn, α–synuclein; ET, electron transfer;
CNS, central nervous system; GSH, Glutathione; NSAID, non-steroidal anti-
inflammatory drugs.
function. Early diagnosis is close to impossible, and because
it often occurs too late, treatment to mitigate the effects of
the illness remains limited. It is, therefore, highly desirable to
understand those complex processes at the molecular level in
order to pave way toward prevention, diagnosis, and treatment.
Biogenic amines are a large group of naturally occurring
biologically active compounds, most of which act as
neurotransmitters—endogenous chemicals that allow the
transmission of signals from a neuron to target cells across
synapses. Neurotransmitters can be excitatory, where there
is a direct communication between the presynaptic neuron
and postsynaptic neuron through the synaptic gap, or
neuromodulators, where the mode of transmission includes
diffusion transport over large distances in the central nervous
system. There are five established amine neurotransmitters:
the three catecholamines (dopamine, noradrenaline, and
adrenaline), histamine, and serotonin. These substances are
active in regulating many centrally mediated body functions,
including behavioral, cognitive, motor and endocrine processes,
and can cause adverse symptomswhen they are out of balance (Di
Giovanni et al., 2008). Despite immense functional importance,
we are currently far from understanding the complex cellular and
molecular actions of biogenic amines, the timing of their release
and the full spectrum of processes that are influenced by them.
An important prerequisite to fully realize the actions of biogenic
amines is to study, at the molecular level, the mechanisms of
both the catalytic activity and inhibition of their metabolic
enzymes, and the way these small molecules interact with larger
systems such as transporters and receptors, which all represent
the starting points for development of tools to diagnose and
drugs to treat specific clusters of symptoms of neurodegenerative
disorders.
Brain monoaminergic systems have been extensively
implicated in the etiology and course of various
neurodegenerative disorders, causing problems with movement
(ataxias) or mental functioning (dementias; Di Giovanni et al.,
2008; Ramsay, 2012). In spite of this, there is, at present, no
effective treatment able to substantially slow down or even stop
the deterioration of neurons resulting in impaired brain function.
All drugs employed nowadays exhibit a range of adverse effects,
and drugs tend to address only symptoms rather than the causes
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of the dysfunction. Early diagnosis is close to impossible and,
because it often occurs too late, treatment to mitigate the effects
of the illness remains limited. In view of this background, the
development of novel compounds for psychiatric manifestations
in neurodegenerative disorders is not only of scientific interest
to advance understanding of the brain at a systems level, but also
fundamental to improving the management of symptoms, the
therapeutic compliance and the quality of life of patients.
The present paper focuses on the use of modern molecular
dynamics and multi-scale methods of computational
biochemistry—from classical molecular dynamics simulations
to quantum mechanical (QM) and combined quantum
mechanical/molecular mechanical (QM/MM) approaches within
the Empirical Valence Bond framework—in order to aid in
understanding of a close relationship between the structure
and function of some biological systems of the brain with
particular focus on a common metabolic enzyme, monoamine
oxidase (MAO), responsible for regulating the concentration
of biogenic, and dietary amines in various parts of the body.
Elucidating the precise atomistic details about the catalytic
activity of MAO enzymes is of paramount importance for
understanding the chemistry of neurodegeneration on molecular
level. The knowledge gained in this area would facilitate research
on other members of the large family of flavoenzymes and
would, in addition to general biochemistry and physiology, be
of significant value for designing and preparing novel effective
MAO inhibitors as transition state analogs, which are potential
clinical drugs for the treatment of depression, Parkinson, and
Alzheimer diseases (Youdim et al., 2006).
CLASSICAL MOLECULAR DYNAMICS OF
PROTEINS
Molecular dynamics simulation (MD) is a powerful
computational technique that provides accurate descriptions of
the structure and dynamics of biological systems, contributing
to their understanding at an atomic level. In MD simulations,
the motion of interacting particles is calculated by integrating
Newton’s equations of motion. The potential energy of the
system and the forces, derived from the negative gradient of the
potential with respect to displacements in a specified direction,
are used to forecast the time evolution of the system in the form
of a trajectory. Equilibrium quantities are then calculated using
statistical mechanics by averaging over trajectories of sufficient
length which would have sampled a representative ensemble of
the state of the system. The potential energies can be obtained by
either classical or quantummechanical methods, with the former
predominant due to reduced computational expense of utilizing
empirical force fields. A force field refers to the functional form
and parameter sets used to calculate the potential energy of a
system of particles classically. A wide variety of force fields for
biological molecules are available including, but not limited
to, CHARMM (Chemistry at Harvard Molecular Mechanics;
Brooks et al., 1983), AMBER (Assisted Model Building with
Energy Requirement; Cornell et al., 1995), and OPLS (Optimized
Potentials for Liquid Simulations; Jorgensen and Tirado-Rives,
1988). Each varies in their functional form and parameters
therein, which are generally obtained to provide a suitable
reproduction of experimental and/or quantum mechanical data.
In classical potentials, atoms are considered as spheres with a
particular mass and associated charge interlinked by springs that
model the bonds. Atomic motions are evaluated using classical
mechanics under the Born-Oppenheimer approximation where
it is assumed that the motion of atomic nuclei and electrons in
a molecule can be separated as a result of the vast difference
in mass between electrons and nuclei. Electrons are said to
adjust “instantaneously” to changes in the nuclear positions,
and they can be ignored when solving the equations of motion.
For this reason, the analytic expression that represents the
energy of a system described by classical potentials is composed
solely by inter- and intra-molecular contributions to the energy
function. The most time-consuming part of the simulation is the
calculation of the non-bonded interactions. A general functional
form includes bond stretching, angle bending, bond rotations,
and non-bonded terms. In general, all these interactions are
calculated between pairs of atoms neglecting the many-body
nature of some of the interactions. This many-body nature refers
to the fact that the motion of every single particle influences
and depends on the motion of the surrounding particles which
would require coupled equations to describe the dynamics of the
system. Classical force fields typically consider effective values of
electronic polarization which is a significant limitation inherent
to all additive force fields, although significant efforts to develop
polarizable force fields for biological molecules have resulted
in several schemes including the fluctuating charge model,
the induced dipole model, and the Drude oscillator approach
(Lamoureux et al., 2003; Patel and Brooks, 2004; Patel et al., 2004;
Shi et al., 2013). A large majority of biomolecular simulation
is currently performed by effectively polarized force fields. In
addition, in order to describe chemical reactions, bond breaking
or forming, nuclear effects, etc., a quantum formulation is
required such as the one described. In systems with a few atoms,
solutions of the aforementioned equation of motions can be
achieved analytically. However, in larger systems, the subsistence
of a continuous potential instigates a many body problem for
force evaluations, rendering analytic solutions unattainable.
Under these circumstances, finite difference methods are
employed and forces are assessed at discrete intervals.
Although the basic idea behind classical molecular dynamics
appears to be rather simple, in practice there are many
complications and one has to be careful at setting the initial
conditions, analyzing in a systematic way the influence of
simulation protocols to ensure reliability, choosing appropriate
algorithms or storing, and analyzing the huge amount of
data generated. Among many applications, classical MD has
become an established tool to identify putative binding sites,
and consequentially establish how drugs function on a molecular
level, to study transport in proteins, to rationalize conformational
changes or to study aggregation and recognition. Nonetheless,
the high computational expense of atomistic MD simulations
for large biological systems remains a significant limitation.
Many biological phenomena occur on extended timescales which
are generally unattainable by classical MD and alternative
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approaches to accelerate sampling have been developed. Coarse-
grained or reduced representations of molecules where a group
of atoms is treated as a single entity or a “bead” are one of such
approaches. By employing classicalMD simulations using coarse-
grained models, larger systems, and longer timescales can be
achieved. In addition, several algorithms also exist to accelerate
sampling along a pre-defined set of reaction coordinates and
estimate the potential of mean force of a process. Enhanced
sampling algorithms are crucial to investigate processes that
involve overcoming an energetic barrier or exceeding the
microsecond timescale, whilst maintaining full atomic detail or
when a substantial system size is required even when considering
a coarse-grained representation. Among these techniques are
thermodynamic integration, umbrella sampling, metadynamics,
adaptive biasing force, steered MD, and many other variants.
With the relentless development of computational algorithms
together with progress in the experimental determination of
three-dimensional structures of membrane proteins and the
increasing speed and availability of supercomputers, it is
now possible to investigate an immense range of biological
phenomenon using MD simulations.
QUANTUM MECHANICAL TREATMENT OF
THE CHEMICAL REACTIVITY
The past century has seen substantial advances, both in
computational techniques and in our understanding of how
enzymes really work. The use of quantum chemical methods to
address enzymatic reaction mechanisms has become a booming
area in enzymology (Ramos and Fernandes, 2008; Lonsdale et al.,
2010; Shaik et al., 2010; Carvalho et al., 2014). Nevertheless,
studying an enzyme at atomic resolution is a computationally
demanding task. In this case, the complexity of the system
prevents resorting to pure quantum-mechanical (QM) methods
to treat the entire system, while the phenomena under study
cannot be accurately represented bymolecular-mechanical (MM)
methods (since MM methods are in their traditional functional
form unable to describe chemical reactions). Currently, there
are two popular approaches to describe enzymatic processes: the
quantummechanics-only (QM-only) (Himo, 2006; Siegbahn and
Borowski, 2006; Siegbahn and Himo, 2011), which uses a small
but carefully selected cluster model of the active site, and the
multiscale quantummechanics/molecular mechanics (QM/MM)
method (Senn and Thiel, 2009; van der Kamp and Mulholland,
2013), which employs a layer-based approach using the entire
protein. Bothmethods have been successfully applied to the study
of various classes of enzymes, and in many cases similar results
and conclusions have been obtained (Ramos and Fernandes,
2008; Shaik et al., 2010).
In the QM-only approach, commonly also called the cluster
approach (Siegbahn and Borowski, 2006), a model of the active
site is designed on the basis of available crystal structures. The
basic idea of this approach for modeling enzyme active sites
and reaction mechanisms is to cut out a relatively small but
well-chosen part of the enzyme and treat it with as accurate
quantum chemical methods as possible. The model should be
a good representation of the whole enzyme, and should behave
and react like the real system. Hybrid density functional theory
(DFT) methods are most frequently used for the calculation of
the geometries and energies of all stationary points along the
reaction pathways. The missing steric and electrostatic effects
from the remaining part of the protein are considered by two
simple procedures. The steric effects imposed by the protein
matrix are taken into account by applying position constraints
to certain key atoms at the periphery of the cluster model, while
electrostatic effects are modeled by the dielectric cavity method,
usually with a dielectric constant of four. In this respect the
experimental structure is included in the calculation. Recent
work even demonstrated that the solvation effects saturate with
increasing the size of a cluster and that the particular choice of
dielectric constant is then no longer of much concern (Liao et al.,
2011).
The first application of the cluster model on an enzyme
reaction mechanism using a high accuracy electronic structure
method was done for methane monooxygenase in 1997
(Siegbahn and Crabtree, 1997). In the past 20 years, the cluster
approach has gradually developed to become more robust and
accurate, a work that is still continuing. For example, different
models of the amino acids were tested (Siegbahn, 2001), and also
how second-shell amino acids should be handled (Pelmenschikov
et al., 2002). As a result of the accelerating computer power,
active site models have become increasingly larger, which has
enabled themodeling of evermore complex problems. At present,
models with up to 200 atoms are often used, which should yield
higher accuracy but has also introduced several new problems
in the modeling, for example, a large number of local geometric
minima. These problems are minimized by trying to limit the size
of the model and include only those residues that are found to
have significant effects. When this is successful, the approach is
extremely powerful and yields a wealth of new information. On
the basis of extensive calculations for a large number of enzymes,
the error of the cluster approach for modeling metalloenzymes
has been assessed by Siegbahn and co-workers to be<5 kcal/mol
(Siegbahn, 2006).
MULTISCALE SIMULATION ON THE
QM/MM LEVEL
Despite a tremendous increase in computer power, including
the availability of tailor-made massively parallelized computer
architectures, together with specialized and more efficient
computer algorithms, it is still impossible to rigorously treat
chemical reactivity in enzymes and solution describing the entire
system at the quantum chemical level. Two key underlying
issues for a correct description of reactions and processes with
chemical character are: (i) an accurate and computationally
efficient description of the bond breaking/forming processes,
and (ii) proper modeling of the complex environment of the
reaction, which involves efficient thermal averaging of the energy
landscape. For converged calculations of free energy profiles for
a typical enzyme reaction with applied position restraints for
reactive species, it is necessary to perform at least a nanosecond
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trajectory, what requires evaluation of forces and energies for a
million configurations. The use of molecular mechanics (MM)
approaches, which are based on classical potentials, is extremely
helpful, as they allow inclusion of environmental effects (either
solvent molecules or enzymes) in a cost-efficient way. However,
traditionalMM force field functional forms are unable to describe
changes in the electronic structure associated with making and
breaking chemical bonds of a system undergoing a chemical
reaction.
A solution to these challenges is the use of multiscale
approaches, in which the interesting part of the system (usually
the reactive atoms plus some additional environment) is
described at the electronic level by high-level QM models, while
the rest of the system is represented by empirical force fields (or
by a lower-level QM method). Multiscale approaches have now
become established state-of-the-art computational techniques for
the modeling of chemical reactions in the condensed phase,
including complex processes in organic chemistry, biochemistry,
and heterogeneous catalysis, among others. Over the past
decade, a number of so-called combined quantum mechanical
and molecular mechanical (QM/MM) methods have been
implemented, using different approximations and interaction
schemes. The award of the 2013 Nobel Prize in Chemistry to
Martin Karplus, Michael Levitt, and Arieh Warshel for “the
development ofmultiscalemodels for complex chemical systems”
has demonstrated how mature and highly important multiscale
simulations for enzymology and drug design are.
Ab initio or DFT QM/MM methods are still computationally
very demanding since they do not allow for well-converged
reaction free energy profiles. The Empirical Valence Bond (EVB)
approach introduced by Warshel and Levitt (1976) was the first
QM/MM method, and after nearly four decades it remains the
most practical approach in computational enzymology and the
computational treatment of chemical reactivity in polar solutions
in general. In their seminal work Theoretical Study of Enzymatic
Reactions: Dielectric, Electrostatic, and Steric Stabilization of the
Carbonium Ion in the Reaction of Lysozyme (Warshel and Levitt,
1976), Warshel and Levitt introduced all of the basic concepts
of the QM/MM methodology, including the partitioning of
the system, the form of the potential energy function, and the
interactions between the QM and MM parts. The rest of this
section will be devoted to the description of EVB that provides
a powerful way to connect classical concepts of physical organic
chemistry to the study of chemical reactions. On purpose, most
of the mathematical formulation is not shown, and the interested
reader is referred to review articles describing progress in EVB
theory and implementation (Olsson et al., 2006; Kamerlin and
Warshel, 2011a,b).
As within a standard Valence Bonds (VB) framework, EVB
uses a set of VB configurations, which can involve covalent,
ionic, or a mixture of bonding types, to describe the reactive
system participating in the chemical reaction. However, in this
case, each VB state corresponds to different bonding patterns
of key essential energy minima (reactants, products, and any
intermediates) along the postulated reaction coordinate. Energy
of covalent bonds is described by Morse functions that allow
for bond breaking and making, while bond angle and dihedral
angle terms are functionally identical to other force fields. For
molecular simulation of a simple SN2 reaction with the EVB
method with graphical interface visit http://www.ki.si/L01/EVB.
Most enzymatic reactions involve high barriers that cannot be
sampled directly by molecular dynamics. In order to calculate
reaction energy profiles in terms of free energy, it is necessary
to proceed with biased sampling in conjunction with a special
method for the free energy calculation. The strategy for this
involves the free-energy perturbation (FEP) approach and the so-
called umbrella sampling (US) procedure. The FEP approach is
based on gradual transformation between the reactant and the
product state using the coupling parameter, λ. At each step, a
molecular dynamics (MD) simulation is performed with fixed λ.
This technique ensures that the system explores areas of the phase
space that would not be accessible otherwise in real time, due to
the high potential energy (i.e., around the transition state).
The reaction barrier, 1G‡, extracted from the computed free
energy profile is directly related to the rate constant k as k =
KBT
h exp
(
−
1G‡
KBT
)
, where T is the absolute temperature while
h and kB are Planck and Boltzmann constant, respectively.
Therefore, once the free energy profiles are computed, they can
be trivially converted into reaction rates. The applied procedure
proved to be computationally robust and allows for practical
calculation of the reaction rates. Currently, many research groups
are actively developing and applying different approaches based
on the EVB philosophy. These recent developments, which
include new methodologies and program packages, have greatly
expanded the scope of problems that can be studied with
EVB, enabling applications from small to large-scale molecular
systems. Still, computational enzymology remains the most
important field where EVB is applied.
EXAMPLES OF CLASSICAL MOLECULAR
DYNAMICS OF MEMBRANE PROTEINS
Neurotransmitters such as dopamine and serotonin play a
central role in the pathophysiology of major neuropsychiatric
illnesses, such as anxiety and mood disorders, schizophrenia,
autism spectrum disorders, Parkinson’s disease, epilepsy,
and dementias. Neurotransmitter-binding proteins such as
receptors, transporters, and common metabolic enzymes are
the starting points for development of tools to diagnose and
drugs to treat specific clusters of symptoms. How these proteins
function on a molecular level, remains largely unresolved. A
fuller understanding is steadily emerging due to the increasing
availability of three-dimensional structures of membrane
proteins, in combination with computational methodologies,
such as molecular dynamics simulations. In this context,
computational labs have focused their efforts in studying at
atomistic level how membrane proteins work probing events
such as selectivity, permeation, gating, or the conformational
changes associated with these processes, and more recently,
on studies illustrating protein-lipid interactions (Domene,
2007; Domene and Furini, 2009; Illingworth and Domene,
2009; Furini and Domene, 2013; Ingolfsson et al., 2014). For
instance, the composition of biological cell membranes is
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integral in controlling the structure, and subsequently function,
of membrane proteins. Cholesterol is an essential component
of the plasma membrane, with concentrations of over 30% in
some tissues (Lange, 1991). It has been identified to be extremely
influential in the functioning of G-protein couple receptors
(GPCR’s) such as the serotonin1A receptor, β2-adrenergic
receptor and the rhodopsin receptor (Burger et al., 2000;
Pucadyil and Chattopadhyay, 2006; Paila and Chattopadhyay,
2010; Oates and Watts, 2011; Jafurulla and Chattopadhyay,
2013). However, the mechanism by which cholesterol modulates
protein structure and function is largely unknown. Various
theories have been proposed throughout the literature suggesting
that cholesterol acts by either varying the physical properties of
the membrane, binding directly to specific sites on the protein
surface, or facilitating interactions with a third party which
biases the activation state. Indeed, these effects may not be
mutually exclusive but act cooperatively. Crystallographic data
of GPCR’s in complex with cholesterol molecules, such as the β2-
adrenergic receptor (Cherezov et al., 2007; Hanson et al., 2008),
β1-adrenergic receptor (Warne et al., 2011), A2A-adenosine
receptor (Liu et al., 2012), 5-HT2B-receptor (Wang et al., 2013),
and metabotropic glutamate type 1 receptor (Wu et al., 2014),
has led to the identification of specific cholesterol interaction
sites. Elucidation of the β2-adrenergic receptor (Hanson et al.,
2008) structure established the cholesterol consensus motif
(CCM), a groove region between helices II and VII constituted
of highly conserved residues and sequence analysis of several
GPCR’s identified additional putative binding sites (Jafurulla
et al., 2011), the cholesterol recognition/interaction amino acid
consensus (CRAC) motif (Li and Papadopoulos, 1998) and the
inverted form of the CRAC motif (Baier et al., 2011), termed the
CARC motif. However, the affinity of cholesterol for these sites
and the influence on the functional state of GPCR’s has not been
widely categorized and thus MD simulations are underway to
investigate the interactions of GPCR’s and cholesterol.
Likewise, ion channels are a large and bio-medically important
family of membrane proteins that constitute significant drug
targets. They govern the electrical properties of themembranes of
excitable cells such as neurons ormyocytes by allowing thousands
of millions of ions to diffuse down their electrochemical gradient
across the membrane. Channels do not stay open all of the time
but they are “gated” by changes in voltage across the membrane,
changes in the pH, the binding of small molecules, etc. This
process is called “gating” and it operates via conformational
changes. One of the keys to rationalize the way drugs modulate
ion channels is to understand the ability of such small molecules
to access their respective binding sites, from which they can
exert an activating or inhibitory effect. Drug access depends
both on the target conformational state as well as on the real-
time dynamics of the residues lining the fenestrations and entry
tunnels of the target. Although many computational studies have
probed the mechanisms of selectivity and gating as well as the
energetics of ion permeation, few have focused on investigating
the existence and characteristics of cavities in ion channels
through which drugs can exert their action. For example,
a recent study in our lab explored the presence, structure
and conformational dynamics of transmembrane fenestrations
accessible by drugs in potassium channels (Jorgensen et al.,
2015). Molecular dynamics simulation trajectories were analyzed
from three potassium channels one from a different family,
a voltage-gated channel, an inward rectifying channel, and a
two-pore domain one. Four lateral fenestrations across the
range of potassium channels studied were identified and using
structural and sequence alignment and analysis was carried
out to characterize the similarities and differences among
the K+-channel subtypes considered. The study rendered
a framework for rationalizing the differential response of
potassium channels to drugs targeting the transmembrane
domain of these proteins and provided insight about the potential
role of lateral fenestrations in K+-channels for drug delivery
and for designing single and multi-target drugs with improved
selectivity.
Another example where MD simulations have recently
contributed to the atomistic understanding of a membrane
protein is that of the transient receptor potential (TRP) ion
channels. The three-dimensional structure of the vanilloid
receptor 1 or TRPV1, and TRPV2 were recently determined
by single particle electron cryo-microscopy, providing the
opportunity to explore ionic conduction in TRP channels at
atomic detail (Liao et al., 2013; Zubcevic et al., 2016). They
constitute an extensive family of cation channels involved in the
ability of organisms to detect noxious mechanical, thermal, and
chemical stimuli that give rise to the perception of pain. TRPV1
is the main representative of a subfamily of thermosensitive
TRP channels that enable a sensation of scalding heat and
pain. Additionally, tissue damage and inflammation products
modulate the channel by decreasing its thermal activation
threshold (∼43◦C). This feature makes the TRPV1 channel an
essential player in the molecular mechanisms responsible for
injury-related hyperalgesia and pain (Brederson et al., 2013;
Julius, 2013). In addition to temperature greater than 43◦C and
acidic conditions, TRPV1 is also activated by capsaicin and allyl
isothiocyanate, the irritating chemical in hot chili peppers and
the pungent compound in mustard and wasabi, respectively
(Everaerts et al., 2011; Julius, 2013). MD simulations using the
TRPV1 channel revealed the presence of three main binding
sites for cations in the transmembrane domain that were not
appreciable in the cryo-EM structure (Darre et al., 2015). Two
rings of acidic residues are disposed at the extracellular side of the
conduction path generating an electrostatic attraction to cations
and a delineating the first binding site. A second binding site was
found at the intracellular side of the selectivity filter, and a further
site in the central water-filled cavity analogous to those observed
in other ion channels. Simulations evidenced the flexibility of
the selectivity filter, the area of the protein that discriminates
the type of ions that permeates the pore that responds to
the type of permeating ions by adjusting the global symmetry
of this area. A comprehensive picture of the thermodynamics
governing the binding of capsaicin to the TRPV1 channel was
also accomplished (Darre and Domene, 2015) by combining
molecular docking, unbiased MD simulations, and free energy
methods in good agreement with earlier experimental reports.
These exploratory calculations have provided an early glimpse
of the amino acids engaged in favorable capsaicin–channel
interactions defining the key structural determinants of the
TRPV1 vanilloid binding site.
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Ion channels modulate electrical signals across cell
membranes and therefore are key in a myriad of physiological
processes. Establishing the mechanisms of selectivity,
conduction, and gating is central in biomedical sciences
studies in order to establish the connection between structure
and function. For many years, molecular dynamics simulations
have been used to explore these relationships, and it is likely that
they will continue to do so in the future, where the challenges lie
initially in tackling systems where the realism of the biological
environment is improved and subsequently in simulating higher
and more complex levels of organization in living systems.
PHARMACOLOGY OF MONOAMINE
OXIDASES
Monoamine oxidases are mitochondrial outer membrane-bound
enzymes that catalyze the oxidative deamination of a broad
range of biogenic and dietary amines into their corresponding
imines, thus playing a critical role in the degradation of
monoamine neurotransmitters in the central and peripheral
nervous systems. They contain the covalently bound cofactor
flavin adenine dinucleotide (FAD) and are, thus, classified as
flavoproteins. Formed imines leave the active site and are then
non-enzymatically hydrolyzed to the final carbonyl compounds
and ammonia. The enzyme itself is regenerated to its active form
by molecular oxygen, O2, which is in turn reduced to hydrogen
peroxide, H2O2, according to the overall equation (Scheme 1):
The aldehyde intermediate is rapidly metabolized, usually
by oxidation via the enzyme aldehyde dehydrogenase to
the corresponding carboxylic acid, or is reduced in some
circumstances to the alcohol or glycol by the enzyme aldehyde
reductase. MAOs operate using the FAD cofactor, which is,
in contrast to the majority of other flavoenzymes, covalently
bound to a cysteine through an 8α-thioether linkage (Miller
and Edmondson, 1999a). During the catalytic reaction, FAD is
reduced to FADH2 by accepting two protons and two electrons
from the substrate. Although having around 70% sequence
identity and a conserved pentapeptidic sequence (Ser-Gly-Gly-
Cys-Tyr) that binds the identical FAD cofactor (Klinman, 2007),
both the A and the B isoforms of MAO differ on the basis of
their substrate affinities and inhibitor sensitivities. However, it
is assumed that they act by the same mechanism. In humans,
MAO A predominates in the gastrointestinal tract, placenta, and
heart, whereas MAO B predominates in platelets and glial cells
in the brain. Both are found in liver where biogenic amines are
rapidly metabolized and excreted. The primary role of MAO in
the gastrointestinal tract is removal of monoamines absorbed
by food in order to prevent their uncontrolled interaction with
the receptors. It is interesting to mention that the required time
for MAO synthesis in the gastrointestinal tract is 2–3 days,
while in the central nervous system it is about 2–3 weeks. Under
normal physiologic conditions, noradrenalin and serotonin
are the preferred substrates of MAO A, while dopamine and
β-phenylethylamine are the preferred substrates of MAOB, while
both isoforms metabolize dopamine, albeit with differing kinetic
parameters. Inhibitors that mainly act on MAO A are used in the
treatment of depression, due to their ability to raise serotonin
concentrations. In contrast, MAO B inhibitors decrease
dopamine degradation and improve motor control in patients
with Parkinson disease. Inhibition of MAOs has a notable
neuroprotective effect, since MAO catalyzed reactions yield
neurotoxic products such as hydrogen peroxide and aldehydes
(Gadda, 2012; Edmondson, 2014; Pavlin et al., 2016). The cloning
of two separate cDNAs encoding two isoforms of MAO by Shih
and co-workers (Bach et al., 1988) provided the basis for a range
of important discoveries, thereby allowing the elucidation of their
biological roles and development of inhibitors. However, despite
tremendous research efforts devoted to MAOs over several
decades, neither the catalytic nor the inhibition mechanisms of
MAO have been unambiguously established.
STRUCTURES OF MAO A AND MAO B
ISOFORMS
Structures of MAO A and MAO B appeared relatively late and
the main obstacle was the protein crystallization. They are trans-
membrane proteins and their crystallization represents a very
demanding task. After successful heterologous over-expression
and purification of recombinant human MAO in yeast or
P. Pastoris (Newton-Vinson et al., 2000; Li et al., 2002), the three-
dimensional structures of human MAO A (Binda et al., 2002;
De Colibus et al., 2005) and MAO B (Son et al., 2008) have
been solved at a resolution of 2.2 Å and 1.65 Å, respectively.
The X–ray structures of both human MAO, A and B, showed
that the active-site cavities extend from the flavin-binding site at
the core to the surface of the protein. The FAD cofactor binding
site is highly conserved between the two enzymes, but several
details in the substrate-binding site showmajor differences. It was
hypothesized that substrate preferences and inhibitor specificities
are attributed to differences between Phe208–Ile335 in MAO A
and Ile199–Tyr326 in MAO B (Li et al., 2006). The covalently-
bound FAD lies at the end of a long tunnel leading from the
outside of the protein close to the membrane surface. The tunnel
is generally considered to be hydrophobic, ending in an aromatic
SCHEME 1 | Overall oxidative deamination of biogenic and dietary amines catalyzed by the MAO enzyme. Amines are enzymatically converted to the
corresponding imines, which leave the MAO active site and are non-enzymatically hydrolyzed to aldehydes.
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cage near the flavin where two tyrosines align the substrate
toward the C4–N5 region of the flavin (Li et al., 2006; Akyuz
et al., 2007). The influence of the catalytic site tyrosines (Tyr398
and Tyr435 in MAO B) has been investigated in careful kinetic
investigation of several mutants. Although neither is essential
to catalysis in terms of complete loss of activity, the affinity for
and turnover of substrates is altered in the mutant enzymes. For
example, the Km for benzylamine increases by more than 10-
fold in the Tyr435Phe mutant (Li et al., 2006). The evidence
reveals a clear role for these tyrosines in aligning the substrate
correctly for catalysis, perpendicular to the N5 and on the re
face of the isoalloxazine ring. These tyrosines also exert a dipole
effect on the substrate that can make the amine more susceptible
to oxidation. The key features of substrate position in the active
site are proximity and orientation relative to the N5–C4a region
of the flavin ring. All these features result in changed activation
free energy and therewith associated rate constants on the point
mutations.
At this point it is worth to emphasize that availability of the
high-resolution MAO structures represents crucial information
for the multiscale simulation of the reactive step and rational
design of both irreversible and reversible inhibitors.
MAO PREORGANIZED ELECTROSTATICS
IS REFLECTED IN THE pKa VALUES
Computational studies gave clear evidence that the enzyme active
sites provide specific polar environments that do not resemble the
gas phase or simple solvent. The enzyme environment is designed
for the electrostatic stabilization of transition states, enabling
solvation higher than in water. Therefore, the bulk of the enzyme
catalytic power originates from the electrostatic preorganization
of its active sites. Essentially, solvent molecules must reorient
during the reaction due to polarization induced by a changing
charge distribution, while this energetic penalty is much smaller
in enzymes, as they provide an electrostatic environment that
has evolved to require much less reorganization. A change
in the protonation states of ionizable residues results in an
altered electrostatic potential pattern in the enzyme, which
gives rise to altered activation free energies and manifests as pH
dependence of the reaction rate. Electrostatic potential of the
enzyme active site is, by definition, a fluctuating scalar field and
cannot be directly measured experimentally. However, there
are few experimentally accessible quantities that are closely
related to the electrostatic potential. Recent studies by the
vibrational Stark effect spectroscopy applied to carbonyl group
stretching give some insight into the preorganized electrostatics.
The authors calibrated the sensitivity of these vibrations to
electric fields and used this calibration to quantitatively interpret
the electric field environment experienced by a probe. The
approach was pioneered by Boxer’s group and applied to
quantify the contribution of electric fields to the catalytic rate
enhancement by the enzyme ketosteroid isomerase (Sigala et al.,
2007; Fried et al., 2014). Much more practical, established and
abundant approach is the measurement and calculation of the
corresponding pKa values.
The pKa values of ionizable residues in the enzyme active
site are an excellent probe for the electrostatic environment,
since pKa is very sensitive to any structural change and
the associated alteration in the electrostatic potential. Since
MAO A and MAO B isozymes are 70% homologous and the
overall geometric matching is high (RMSD between the X–ray
structures is only 0.66 Å), it is reasonable to expect that their
electrostatic potential pattern in the active site will be quite
similar and accompanied by a similarity in the pKa values
of the corresponding residues. It is worth to stress that, in
contrast to the point-wise electrostatic potential comparison, pKa
values can also be determined experimentally. Change of the
pKa value is also a measure of hydrophobicity: hydrophobic
environment does not favor presence of charged species giving
rise to significant shifts in the pKa values. Despite the fact that
monoamines are predominantly monocations at a physiological
pH of 7.4, a hydrophobic active site in MAOs has been proposed
to favor unprotonated substrates. Furthermore, every catalytic
proposal to date has agreed that the substrate must be neutral
for the reaction to take place. Active site pKa values are difficult
to determine experimentally and, similarly, while experimental
pH rate profiles can provide tremendous insight, it can be
hard to conclusively determine the identity of residues whose
protonation state is being affected. For MAO some attempts were
performed to determine pKa values of some surface residues
(Dunn et al., 2008; Repic´ et al., 2014a). The work of Scrutton
and co-workers addressed the pKa values of the enzyme active
site and the substrates (Dunn et al., 2008). The authors studied
pH dependence of MAO A kinetic parameters by stopped-flow
and steady state methodology and H/D isotope substitution. The
authors came to a conclusion that substrates such as benzylamine,
kynuramine, and phenylethyl amine bind in the protonated form,
while deprotonation is required for chemical step. Moreover,
the authors have demonstrated that the pH dependence of the
kinetic isotope effect decreases from ∼13 to 8 with increasing
pH, leading to the assignment of this catalytically important
deprotonation of the amine substrate. The strong H/D kinetic
isotope effect dependence gives evidence that at low pH values
the substrate deprotonation interferes with the rate-limiting step.
Moreover, Scrutton and co-workers suggested that the pKa values
of the studies substrates are decreased for about 2 pKa units
when transferring the substrate from aqueous solution to the
enzyme. To get an insight into the nature of the MAO active
sites, the pKa values of a few ionisable residues were calculated
in order to compare the electrostatic potential pattern in the
active sites of both isoforms (Dunn et al., 2008). Well-converged
free energy calculations of the pKa values were performed
using the MOLARIS program package together with an all-atom
representation of the solvated enzymes. In line with the general
consensus that dopamine enters the chemical step in a neutral
form, a neutral dopamine molecule was manually docked in the
active site in a way suitable for the catalytic step. We chose
only one substrate on purpose in order to avoid the effects
associated with ligands of different sizes on the pKa values. pKa
calculations were performed using the semimacroscopic protein
dipole/Langevin dipole approach of Warshel and co-workers
in its linear response approximation version (PDLD/S–LRA),
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allowing for converged free energy calculations (Lee et al., 1993;
Schutz and Warshel, 2001).
The calculated pKa values are sensitive to the applied external
dielectric constant during simulations. The choice of the correct
dielectric constant to describe the protein interior is a very
complex issue and has been the subject of heated debates
over the years (Schutz and Warshel, 2001). In our work, we
employed ε = 10–16, still, due to the focus on the relative
difference between pKa values in MAO A and MAO B, the
choice would not change the qualitative picture and is thus
of lesser importance. Specifically, we have examined the pKa
values of four tyrosine residues that are part of the so-called
aromatic cage and a Lys residue close to the reacting atoms of
FAD. Among isoforms, the average absolute differences over a
dielectric constant of 10–16 in the corresponding pKa values are
assumed to be 0.05, 0.07, 0.12, 0.75, and 1.23 for MAO A/B pairs
Tyr69/Tyr60, Lys305/Lys296, Tyr407/Tyr398, Tyr444/Tyr435,
and Tyr197/Tyr188, respectively. These results clearly
demonstrate that, for both isozymes, the pKa values for the Tyr
and Lys residues in question are not substantially different (1.23
pKa units at maximum), thus providing strong evidence that the
electrostatic potential pattern in the active sites of both isozymes
is very closely matched. Since enzymes work by preorganized
electrostatics, the same electrostatic environment cannot be at
the same time suitable for optimal solvation of the transition
state with a positive and a negative charge build-up, as would
be the case in the hydride and polar nucleophilic mechanisms.
Superimposition of both experimental X-ray structures also
reveals a high similarity in the spatial configuration of charged
groups in MAOs (Figure 1). It is therefore unlikely that MAO A
and MAO B would work by different chemical mechanisms on
the same family of substrates, thus contradicting an interesting
proposal of Orru and co-workers (Orru et al., 2013). The pKa
value of the bound dopamine (8.8) is practically unchanged
compared to the corresponding value in aqueous solution
(8.9), as would be expected from a charged amine placed
in a hydrophobic active site consisting of aromatic moieties
(Li et al., 2006). The MAO active sites are in this respect
not hydrophobic and practically unchanged dopamine pKa
relative to aqueous solution may be attributed to favorable
cation–pi interactions between the dopamine –NH+3 group
and aromatic moieties, which provide a stabilizing effect to
the charged fragment. Our results can be contrasted with the
study of Scrutton and co-workers reporting the pKa shift of
the substrates for about 2 pKa units. The discrepancy can
be, among other factors, explained by the sizes of different
substrates.
MECHANISTIC STUDIES OF MONOAMINE
OXIDASE BY QUANTUM MECHANICAL
CLUSTER MODEL
The general reaction of flavin amine oxidases, including MAO,
can be divided into two half-reactions. In the reductive half-
reaction, a hydride equivalent is transferred from the substrate
to the flavin, thus reducing it to FADH2, while the oxidative
half-reaction involves the oxidation of the reduced flavin back to
FAD by molecular oxygen, producing H2O2 (Scheme 1).
The chemical mechanism of the reductive half-reaction in
MAO has been the source of controversy and debate (MacMillar
et al., 2011). Oxidation of an amine substrate necessarily involves
the removal of two protons and two electrons as the carbon–
nitrogen single bond is converted to a double bond. Three-
dimensional structures of MAO A and MAO B isoforms (Binda
et al., 2002; De Colibus et al., 2005; Son et al., 2008), together with
extensive kinetic and spectroscopic studies on mutant enzymes
(Binda et al., 2002; De Colibus et al., 2005; Li et al., 2006), have led
researchers to propose three possible catalytic scenarios for MAO
(MacMillar et al., 2011): (a) the direct hydridemechanism, (b) the
radical mechanism, and (c) the polar nucleophilic mechanism.
Studies on deuterated substrate analogs have suggested that the
rate-limiting step is the cleavage of a carbon-hydrogen bond
vicinal to the amino group (Klinman and Matthews, 1985) and,
hence, the catalytic proposals differ in the nature of the hydrogen
being transferred, namely a hydride (H−) in (a), a hydrogen atom
(H•) in (b), and a proton (H+) in (c) (Walker and Edmondson,
1994; Wang and Edmondson, 2011), commonly by the flavin
N5 atom. In contrast, the other hydrogen from the amino N–H
moiety is generally proposed to be abstracted as a proton (Harris
et al., 2001). Thus, establishing the MAO catalytic mechanism
necessarily requires the knowledge of the timing of the removal
of hydrogens from both the carbon and nitrogen atoms.
The possibility of the hydridemechanism forMAOswas based
on their structural similarities to flavoprotein D-amino acid
oxidases (DAAO), for which both kinetic measurements (Kurtz
et al., 2000; Ralph et al., 2007) and related calculations (Ralph
et al., 2007) suggested a hydride or a single electron transfer.
Additionally, deuterium and 15N kinetic isotope effect studies
of flavin amine oxidases including DAAO (Kurtz et al., 2000),
tryptophan-2-monooxygenase (TMO; Ralph et al., 2006), and N-
methyltryptophan oxidase (MTOX; Ralph et al., 2007), are most
consistent with a hydride transfer mechanism. However, Erdem
et al. (2006) assumed that a hydride mechanism was unlikely, and
concluded that in MAO it would be associated with a barrier
too high to be readily crossed. In addition, a combined 15N
and deuterium isotope effects demonstrated that the C–H bond
cleavage is not concerted with the rehybridization of the substrate
amino group (MacMillar et al., 2011), which seem to rule out the
feasibility of a concerted hydride transfer mechanism.
According to Silverman and co-workers (Silverman, 1995)
the radical mechanism is initiated by a single-electron transfer
from the substrate to the flavin, producing an aminium radical
cation and a flavin semiquinone as transient intermediates. The
lowered pKa of the α–CH bond of the aminium radical cation
can result in either a stepwise (Silverman, 1995) or concerted
(Vintém et al., 2005) deprotonation and a second electron
transfer producing reduced flavin and the iminium ion. The
main supporting evidence for the radical mechanism is the
observation that bothMAOs are inactivated by cyclopropylamine
analogs with subsequent ring opening, a process characteristic
of radical reactions (Silverman, 1983). An argument against
the radical mechanism has been the failure of any laboratory
to detect semiquinone radical species during turnover in a
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FIGURE 1 | Superposition of FAD and ionisable residues surrounding the active site (MAO A is red, MAO B is blue).
stopped-flow monitored reduction or using radical traps (see
later). The chemistry of the cyclopropylamine probes and
resulting products supported the view that single electron
transfer is possible at least with these compounds, but the
lack of inactivation by, and a ring-opened product from
trans-2-phenyl(aminomethyl)cyclopropane suggested that other
mechanisms must be possible (Fitzpatrick, 2010). In a modified
single electron transfer mechanism, the involvement of protein-
based radicals has also been proposed but questioned (Rigby
et al., 2005; Kay et al., 2007). Mutation of the substrate-orienting
tyrosines and isotopic labeling of the tyrosines in MAO A, and
the fungal counterpart MAO B, provide evidence for radicals
delocalized away from the active site (Dunn et al., 2010).
The experiments by Edmondson and co-workers (Walker
and Edmondson, 1994), as well as related electron paramagnetic
resonance studies (Tan et al., 1983; Miller et al., 1995; Nandigama
and Edmondson, 2000) and stopped-flow kinetic determinations
(Nandigama and Edmondson, 2000), failed to provide any
evidence for radical intermediates, and no influence of the
magnetic field on the kinetics of enzyme reduction was observed
(Miller et al., 1995). In addition, Taft correlation studies of
Miller and Edmondson with benzylamines showed that attaching
the electron-withdrawing groups to the substrate para-position
increases the rate of the reaction in both human (Miller and
Edmondson, 1999a) and rat (Wang and Edmondson, 2011)
MAO A, implying negative charge build-up on the substrate
Frontiers in Neuroscience | www.frontiersin.org 10 July 2016 | Volume 10 | Article 327
Vianello et al. Multiscale Simulations in Understanding Neurodegeneration
α–carbon atom, thus suggesting that proton transfer is an
integral part of the rate limiting step. This led authors to
propose the polar nucleophilic mechanism for MAO A (Miller
and Edmondson, 1999b), originally formulated by Hamilton
(Hamilton, 1971). This mechanism involves the creation of a
highly energetic substrate–flavin adduct which then decomposes
to the protonated imine, with proton abstraction concerted with
either the adduct formation or the product formation. The crucial
issue related to this mechanism is what moiety on the enzyme
would be strong enough base to perform this task, since the
pKa of a benzyl proton is expected to be around 25 (Smith
and March, 2001). Structural analysis of both MAO isoforms
showed there are no active site basic residues that could act as
proton acceptors. Also, no direct evidence for a stable amine–
flavin adduct has been found experimentally. A study on human
MAO B, however, showed an inverse Taft correlation (Orru et al.,
2013), supporting the hydride transfer mechanism, which led
the authors to propose different mechanisms for two isozymes:
H+ transfer in MAO A and H− transfer in MAO B, although,
the same authors had previously ruled out H− transfer in
human MAO B, based on the nitrogen secondary kinetic isotope
effects (MacMillar et al., 2011). Based on the similarities in the
continuous wave electronic paramagnetic resonance spectrum
between MAO and D-amino acid oxidase, determined to operate
by the H− transfer mechanism (Umhau et al., 2000), Kay and
co-workers suggested a hydride transfermechanism should be re-
examined for MAO (Kay et al., 2007). Therefore, it is clear that,
despite the widespread use of MAO inhibitors, the mechanism of
MAO catalysis is not unambiguously determined which calls for
its rationalization using advanced computational techniques.
The first computational study on the complete mechanism
of MAO catalysis was performed by our groups (Vianello et al.,
2012), employing DFT methodology within the cluster model
of the enzyme. The starting point for our calculations was the
high-resolution (1.6 Å) X-ray structure of MAO B complexed
with 2-(2-benzofuranyl)-2-imidazoline (accession code 2XFN;
De Colibus et al., 2005). We truncated the enzyme to the flavin
moiety (isoalloxazine group 2, Figure 2) and three tyrosine
side-chains (p-hydroxytoluenes of Tyr188, Tyr398, and Tyr435),
which all form the mentioned hydrophobic “aromatic cage”
(Li et al., 2006; Akyuz et al., 2007). Previously, we calculated
the pKa values of the Tyr residues with bound dopamine
(Borštnar et al., 2012), and obtained an upward shift to 13.0–
14.7 (pKa for Tyr in aqueous solution is 10.1). This clearly
confirmed the hydrophobic nature of the active site, which
indicates that gas-phase calculations on truncated MAOs are
reliable. Also, we showed that the pKa value of bound dopamine
changes to only 8.8 (8.9 in aqueous solution), a result of
stabilizing cation–pi interactions with the tyrosine side-chains
(Borštnar et al., 2012). This implies that dopamine binds to
the MAO active site as a protonated monocation, but the free-
energy cost to deprotonate it to the bulk, being as low as 1.9
kcal mol−1, allows it to enter the chemical step either as an
ionized or neutral molecule, which led us to consider both
alternatives. Based on crystal structures (Binda et al., 2002; De
Colibus et al., 2005; Son et al., 2008) and our MD simulations
(Borštnar et al., 2012) that both indicate the presence of few
FIGURE 2 | Structures of dopamine (1) and isoalloxazine moiety (2) of
the FAD cofactor used in the cluster model of the MAO active site.
water molecules in the active site, our model also included
four crystal water molecules (HOH2157, HOH2181, HOH2329,
and HOH2372). It turned out that two of those are chemically
involved in catalysis. We manually placed dopamine 1 within the
cluster, resulting in the initial stationary-point (SP) complexes
(Figure 3). The system was modeled at the (CPCM)/M06–
2X/6–311++G(2df,2pd)//(CPCM)/M06–2X/6–31+G(d) level of
theory employing the M06–2X functional designed by Zhao
and Truhlar to accurately reproduce thermodynamic and kinetic
parameters (Zhao and Truhlar, 2008, 2011; Bell and Head-
Gordon, 2011; Cheong et al., 2011; Picek et al., 2015; Saftic´
et al., 2015), being particularly successful in treating non-bonding
interactions. To account for the polarization effects caused by
the rest of the enzyme, we included a conductor-like polarizable
continuum model (CPCM) (Cossi et al., 2003) with a dielectric
constant of ε= 4, taking the rest of the parameters for pure water,
as employed in many studies by Siegbahn, Himo and their co-
workers in elucidating the catalytic mechanism of a large variety
of enzymes (Himo, 2006; Siegbahn and Borowski, 2006; Siegbahn
and Himo, 2011).
For 1SP1 (Figure 3) we first considered the single-electron
radical mechanism, which would initially create a biradical either
in the singlet or triplet electronic states. (CPCM)/UM06–2X/6–
31+G(d) calculations for the triplet state produced the system
54.2 kcal mol−1 higher in energy than 1SP1. For the singlet
state, we employed “symmetry-broken” open-shell calculations,
defining dopamine and the rest of the system as two different
fragments each having an unpaired electron of opposite spin,
which resulted in a stable wave-function with both the energy
and electron distribution identical to that in 1SP1. Overall, this
suggests that the singlet-state biradical is non-existent, whereas
the free-energy cost to generate the triplet is too high for
an efficient catalysis. This agrees well with the experimentally
observed mismatch between the oxidation/reduction potentials
of the FAD cofactor, which is too low (−0.2 V; Newton-Vinson
and Edmondson, 1999) for it to be an effective oxidant of the
neutral amine (around +1.0–1.5 V) (Hull et al., 1969). On top
of the fact that there is no experimental evidence for a radical
intermediate, our results suggest that it is very unlikely that a
radical pathway is feasible and we did not consider it further.
The polar nucleophilic mechanism is another alternative for
the amine oxidation and involves proton abstraction from the α–
carbon atom as the rate-limiting step (Miller and Edmondson,
1999b). The crucial issue relating to this mechanism is what
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FIGURE 3 | Structures of relevant stationary points for the newly proposed two-step MAO catalytic hydride mechanism for the degradation of
dopamine 1.
moiety on the enzyme would be a strong enough base to perform
this task, because the pKa of a benzyl proton is expected to be
around 25 (Smith and March, 2001). Structural analysis of both
MAO isoforms shows there are no basic active-site residues that
could act as proton acceptors (Binda et al., 2003). Edmondson
and coworkers upheld their arguments by stating that in MAOs
the flavin is bent by around 30◦ from planarity about the N5–
N10 axis (Binda et al., 2003), which enhances the basicity of the
N5 atom and depletes the electron density on the C4a atom, thus
facilitating substrate–flavin complex formation with the former
flavin site making subsequent proton abstraction possible. We
feel that, even if all of these effects are operational, it would still
be insufficient to downshift the substrate pKa value by around
10–15 units in order to make the α–CH bond acidic enough
for an efficient catalysis. Furthermore, a relaxed-geometry scan
of the latter bond, by compressing it with 0.1 Å increments,
showed no indication of the formation of a stable complex.
In addition, NBO charges on the flavin C4a and N5 sites and
the substrate N atom in 1SP1 are 0.13, −0.35, and −0.97|e|,
respectively, which demonstrate that they do not change much
from the values found in isolated flavin 2 and dopamine 1
(0.10, −0.34, and −0.93|e|; Table 1), and that there is no charge
transfer already in the Michaellis complex, as proposed by some
authors in favor of the polar nucleophilic mechanism (Abad et al.,
2013). This all indicates that neutral amines do not exhibit the
necessary nucleophilicity to readily add to the flavin C4a position,
in agreement with the fact that no direct evidence for a stable
amine–flavin adduct has been found experimentally. Taken all
together, these results also led us to rule out this mechanism as
feasible.
The geometry of stationary structure 1SP1 (Figure 3) suggests
that the following two pathways are possible. The substrate amino
group is connected through two active-site water molecules to
the flavin N1 atom, which is the most basic position within the
isoalloxazine moiety (Vianello et al., 2012). This implies that
the substrate could be first activated by amino deprotonation
to the flavin N1 site. Also, the α–C(substrate) · · ·N5 bond
length in 1SP1 is 3.198 Å, being sufficiently short to suggest
that the substrate is properly oriented for a direct α–CH
abstraction.
Deprotonation of the neutral substrate amino group is
feasible, but the process is associated with a large barrier of
37.3 kcal mol−1 (Figure 4; Vianello et al., 2012). The transition-
state structure 1TS1 has one imaginary frequency of 270i cm−1
and the corresponding eigenvector represents a proton transfer
to the flavin N1 atom assisted by two water molecules by the
de Grotthuss mechanism (de Grotthuss, 1806). Such a high
energy requirement is rationalized by the large difference in the
pKa values between proton donor and acceptor sites. For the
flavin N1–H deprotonation pKa was measured to be around
7.0 (Macheroux et al., 2005), whereas amine deprotonation
typically has a pKa of around 35 (Smith and March, 2001). Upon
proton removal, the anionic substrate turns nucleophilic and
covalently binds to the flavin C4a atom. The formed complex
facilitates subsequent H− abstraction from the α–CH group,
requiring only 13.2 kcal mol−1 to arrive at the transition-state
structure 1TS2 (υimag = 871i cm−1). Abstraction of the H−
is concerted with the loosening of the N(substrate) · · ·C4a
bond from 2.439 Å in 2TS2–N to 3.505 Å in the final products
1SP3, being reduced flavin FADH2 and neutral imine. This
pathway is associated with collective activation energy of 44.6
kcal mol−1, which is too high to be feasible. In an analogous
pathway, only starting from the substrate with the protonated
amino group, the flavin N1 deprotonation of the –NH+3 group
becomes easier requiring only 20.7 kcal mol−1 (υ imag = 980i
cm−1) The subsequent α–hydride abstraction by the flavin N5
atom costs an additional 24.4 kcal mol−1 to add up to an
overall reaction free-energy barrier of 43.1 kcal mol−1, yielding
protonated imine, R–CH2CH2 = NH
+
2 . Although the collective
activation barrier for this process is slightly lower than with the
unionized substrate, it is still too high for this mechanism to be
plausible.
Traditional notion of the hydride abstraction should generate
positive charge on the substrate α–carbon atom, which would
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TABLE 1 | Evolution of atomic charges during the C(α)–H hydride abstraction reaction from dopamine to flavin as obtained with the NBO approach at the
(CPCM)/M06–2X/6–31G(d) level of theory.
System Atom/group Isolated Reactants (1SP1) TS (2TS1) Intermediate (2SP2)
N(amino) −0.93 −0.97 −0.79 −0.90
α–C −0.26 −0.25 −0.11 0.16
β–C −0.50 −0.49 −0.50 −0.52
C1(phenyl) −0.06 −0.04 −0.06 −0.07
dopamine 0.00 −0.03 0.31 0.43
N5(flavin) −0.34 −0.35 −0.50 −0.50
N1(flavin) −0.63 −0.68 −0.71 −0.70
flavin 0.00 0.01 −0.29 −0.35
FIGURE 4 | Free-energy profiles for the MAO catalyzed amine degradation reaction initiated by either amino deprotonation (A), or a direct hydride
abstraction (B) as obtained with the (CPCM)/M06–2X/6–311++G(2df,2pd)//(CPCM)/M06–2X/6–31+G(d) model employing the cluster model of the
enzyme.
seem to contrast the aforementioned positive Taft correlation
(Miller and Edmondson, 1999a) that suggested negative charge
development on the stated carbon atom. However, due to
H− abstraction, the depletion of electron density on the α–
carbon atom is completely outperformed by the strong electron-
donating ability of the vicinal amino group, as evidenced by
a decrease in both the corresponding N(amino)–C(α) bond
length and the nitrogen atomic charge from 1.466 Å and 0.97|e|
in 1SP1 to 1.354 Å and −0.79|e| in 2TS1. As a result, the
charge on the α–carbon atom changes from −0.25|e| in 1SP1
to −0.11|e| in 2TS1, surprisingly preserving a significant portion
of the negative charge (Table 1). More importantly, the charge
on the dopamine β–carbon atom, which is in terms of para-
substituent effects analogous to the benzylamine α–carbon atom,
even increases from −0.49|e| (1SP1) to −0.50|e| (2TS1), which,
taken all together, gives strong evidence to why this reaction
is facilitated by the electron-withdrawing para-substituents on
the aromatic ring, thus putting our results in firm agreement
with the work of Miller and Edmondson (1999a,b). After the
flavin accommodates H−, its N5 atom becomes sp3–hybridized
with excess negative charge, having enough nucleophilicity to
form a covalent bond with the thus formed cationic substrate
(Figures 3, 4). Macheroux et al. (2005) measured the pKa
value of the fully hydrogenated flavin N(5)–H2 moiety to be
pKa = 4, which indicates that the N(5)–H− group possesses
sufficient basicity to act as a base. The calculated substrate–
flavin interaction free energy in 2SP2 is as high as 27.7 kcal
mol−1, which, together with the corresponding N5–C(α) bond
length of only 1.703 Å, suggests that the formed complex is
rather strong. With the complex formation, the necessity for
another step in this process becomes apparent, which represents
an important advantage over other mechanistic proposals that
all advise protonated imine as the final product. We disagree
with the latter for two reasons. First, it would be difficult for a
protonated imine to leave the active site, because on its way out
it would relatively strongly bind to the “aromatic cage” through
favorable cation–pi interactions (Borštnar et al., 2012). Secondly,
it is well-established that the final imine hydrolysis to aldehydes
occurs non-enzymatically outside the MAO (Edmondson et al.,
1993; Woo and Silverman, 1995). However, the protonated
product would immediately be hydrolyzed by the nearest water
molecule within the enzyme, because in organic chemistry this
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reaction readily proceeds with the protonated imine under acidic
conditions (Smith and March, 2001).
The next step involves amino group deprotonation by the
flavin N1 atom with an activation free energy of 9.4 kcal mol−1
(Figure 4), being concerted with the weakening of the adduct
N5(flavin) · · ·Cα(dopamine) bond. The transition-state 2TS2
(υimag = 933i cm−1) again describes a de Grotthuss-type proton
transfer proceeding with the two active-site water molecules.
Upon deprotonation, the system is stabilized by 10.1 kcal mol−1
to 2SP3, making the whole reaction energetically feasible and
yielding the neutral trans-imine and the fully reduced flavin
(FADH2) as final products (Figures 3, 4). It has to be strongly
emphasized that the presence of the acidic N–H bond enables
the completion of MAO turnover and explains why many alkyl-
and arylamines change from being MAO substrates to MAO
inhibitors upon N,N-dimethylation (Ding et al., 1993). The fact
that dopamine is converted into a neutral imine is significant,
because this suggests it will predominantly remain unprotonated
in the hydrophobic active site, based on consideration of the
pKa values of similar unconjugated imines, which are, as a rule,
found to be below the physiological value of 7.4 (for example,
the pKa value of Me2C=N−Me is 5.5) (Smith and March, 2001),
ensuring that the neutral product could go past the “aromatic
cage” on its release from the active site. This, however, does not
rule out the possibility that, when it is finally liberated from the
enzyme, the imine formed could be readily protonated, because,
during its departure, changes in the environment could make
the protonation feasible. It is also possible that the protonation
occurs already close to the active site since hydrated enzyme
represents proton rich environment. This would then fully agree
with Edmondson et al. (1993), who showed that the protonated
p-(dimethylamino) benzylimine is released from the enzyme.
Also, the fact that flavin is fully reduced to FADH2 enables
an important prerequisite for MAO regeneration by molecular
oxygen to revert flavin into its oxidized form (FAD) by creating
hydrogen peroxide (H2O2), a reaction for which two hydrogen
atoms are required (Scheme 1). Please note that hydrogen
peroxide further reacts and produces reactive oxygen species that
are responsible for the oxidative stress and neurodegeneration
(vide infra).
In concluding this section, let us emphasize that presented
results have convincingly demonstrated the prevailing feasibility
of the two-step hydride transfer mechanism (Figure 5). In recent
years, there have been several additional computational studies
showing its prevailing feasibility in MAO (Akyüz and Erdem,
2013; Atalay and Erdem, 2013; Zapata-Torres et al., 2015), or
some other flavoenzymes (Kopacz et al., 2014; Karasulu and
Thiel, 2015). Furthermore, in what follows, we will demonstrate
that when we moved from the QM-only cluster model toward
including the full enzyme structure, via the Empirical Valence
Bond QM/MM approach, the calculated activation free energy
for the MAO B catalyzed degradation of dopamine drops down
to 1G‡ = 16.1 kcal/mol (Repic´ et al., 2014b), being in excellent
agreement with the available experimental value of 16.5 kcal/mol
(Walker and Edmondson, 1994; Wang and Edmondson, 2011),
thus providing a strong support for our mechanistic picture.
MULTISCALE SIMULATION OF MAO
CATALYZED CHEMICAL STEP FOR
DIFFERENT SUBSTRATES
In this section, we focus to the extension of the static cluster
model study of the rate-limiting step in MAO B to a full enzyme
dimensionality using multiscale EVB approach with extensive
thermal averaging allowing for a direct evaluation of the enzyme
catalytic effect compared to the reference reaction in the gas
phase or aqueous solution (Warshel, 2014).
For enzyme reactions and reactions in polar solutions,
transition state theory is practically always valid. To calculate
the rate constant for the reaction it is, therefore, necessary to
know the barrier height in terms of free energy. Faster reaction
has lower barrier than the slower one. Catalysis is the reaction
rate enhancement relative to the reference reaction and catalyzed
reaction has, therefore, lower free energy of activation than
the uncatalyzed reaction. The natural reference state for an
enzymatic reaction is the corresponding uncatalyzed reaction
in aqueous solution, since biology occurs in this medium.
However, considering the lack of direct experimental kinetic
data in aqueous solution, our calculated reference state for
the MAO B catalyzed reaction is the corresponding hydride
transfer in the gas phase, as this is the state for which one is
most likely to obtain reliable estimates of the activation barrier
using quantum chemical approaches. For the gas phase reference
reaction between lumiflavin 2 and dopamine 1 we used the
optimized geometries of the reactants and transition state from
the cluster study. The gas phase energetics of the reaction were
calculated using the M06–2X density functional in conjunction
with the 6–31+G(d,p) basis set as described in previous section.
For simulation using full dimensionality of the enzyme with
included water molecules, atomic coordinates were obtained
from the high-resolution (1.6 Å) crystal structure of MAO B
obtained from the ProteinData Bank (accession code 2XFN). The
charges of all relevant structures were fitted to the electrostatic
potential and calculated with inclusion of the solvent reaction
field at the (CPCM)/B3LYP/6–311G(d,p) level. The dopamine
substrate was manually docked into the MAO B active site. EVB
calculations were performed in vacuo representing the reference
state, aqueous solution as well as full dimensionality of the MAO
B enzyme, to examine the effect of different environments on the
reaction barrier. For all EVB calculations the same EVB region
was used, consisting of lumiflavin moiety and dopamine for a
total simulation time of 15.3 ns, while for other technical details
the reader is referred to the original publication (Repic´ et al.,
2014b). All EVB calculations were performed using the standard
EVB free energy perturbation/umbrella sampling (EVB–FEP/US)
procedure (Kamerlin and Warshel, 2011b) and the MOLARIS
simulation package in combination with the ENZYMIX force
field (Schutz and Warshel, 2001).
In order to study enzyme catalysis, it is highly desirable to
have the experimental kinetic data for the reference reaction in
aqueous solution. To our best knowledge experimental kinetic
data for the reaction between flavin and dopamine in aqueous
solution are not available. There are also no available data
Frontiers in Neuroscience | www.frontiersin.org 14 July 2016 | Volume 10 | Article 327
Vianello et al. Multiscale Simulations in Understanding Neurodegeneration
FIGURE 5 | Complete two-step mechanism for MAO catalyzed amine degradation. The first step involves H− abstraction from the substrate to form the
flavin–substrate adduct, which then decomposes to the final products, namely neutral imine and fully reduced flavin, FADH2, a reaction promoted by amine
deprotonation facilitated by two water molecules.
about the kinetics of uncatalyzed reactions between flavins and
phenethylamines or some suitable model compounds. Some
studies has shown that flavins react with amines and alcohols
in aqueous solution on a timescale of days, but no further
kinetic data were provided and, therefore, experimental value for
activation free energy of the reference reaction cannot be deduced
(Brown and Hamilton, 1970; Kim et al., 1993). Therefore, we
parameterized our EVB Hamiltonian to reproduce reliable M06–
2X/6–31+G(d,p) energetics in vacuo (1G‡gas and 1G0gas). The
system was subsequently moved to aqueous solution and to
the MAO B active site using the same parameter set (EVB
off-diagonal term plus the gas phase shift). This is a valid
approximation, due to the demonstrated phase-independence of
the EVB off-diagonal (Hij) coupling term (Hong et al., 2006).
To model the hydride transfer step using EVB, the activation
free energy (1G‡gas) and the free energy (1G0gas) of the reference
reaction need to be known. While it is straightforward to obtain
1G‡gas, the calculation of 1G0gas is complicated by the fact that,
in the gas phase, the resulting FADH2 anion and dopamine
cation form a bound adduct immediately upon hydride transfer.
In order to circumvent this issue we selected the point in
the Intrinsic Reaction Coordinate (IRC) profile where the
structure of FADH− moiety matches the geometry of the gas-
phase optimized FADH−. In addition, the IRC profile shows
a shoulder in the potential energy surface around the same
point, thus suggesting a transient intermediate. Full geometrical
optimization of the reactant, the transition state, and the adduct,
including the thermal correction to Gibbs free energy, shows that
the transition state and adduct are 32.8 and 10.0 kcal mol−1
higher in energy than the reactants, respectively. Taking into
account the thermal correction, the product is 24.9 kcal mol−1
higher in energy than the reactants. The EVB gas-phase shift and
coupling parameter were thus parameterized to reproduce these
1G‡gas and 1G0gas values. Using the same parameters as in the
gas-phase EVB simulation the reaction in aqueous solution and
in the enzyme was simulated. In aqueous solution the activation
free energy is still high, 26.5 kcal mol−1, it is lowered by 6.3
kcal mol−1 relative to the gas phase. Even more pronounced
is the effect of the aqueous environment to the free energy of
reaction, which is lowered to 4.2 kcal mol−1. By inclusion of
the full dimensionality of the enzyme environment, reduction
of the barrier to 14.2 kcal mol−1 is observed and the reaction
becomes exergonic with a reaction free energy of−0.6 kcal mol−1
(Repic´ et al., 2014b). The reduction in the activation barrier
compared to the aqueous solution is 12.3 kcal mol−1, which
corresponds to a rate-enhancement of more than nine orders of
magnitude. The reaction is not excessively exergonic, allowing
for the reverse reaction in the case of product overproduction.
Experimental studies revealed that the substrates are bound to
the MAO B active site in the protonated form, while they enter
the reaction only if they are neutral. We calculated the pKa
value for dopamine placed at the MAO B active site and we
have shown that it is not significantly changed relative to its
value in water. The reversible work necessary for dopamine
deprotonation can be calculated then analytically and its value is
1.9 kcal mol−1. When this correction is added to the calculated
barrier of 14.2 kcal mol−1, it gives an activation free energy
of 16.1 kcal mol−1. The latter is in excellent agreement with
the experimental value of 16.5 kcal mol−1 (Edmondson et al.,
2009) thus strongly supporting the proposed hydride transfer
mechanism. A snapshot from the simulation of MAO B active
site with the reactive dopamine molecule is shown in Figure 6.
The Lys296 residue is a part of the FAD–H2O–Lys296 motif
conserved in many flavin-dependent oxidases and we speculated
that it might be important in the MAO catalysis. We have
performed our calculations with both the neutral and protonated
form of Lys296 to quantify the effect of the ionization state of
this residue on the hydride transfer reaction. Our results show
that the protonation state of Lys296 does not affect the reductive
half-reaction of MAO B and that the barrier for the reaction
is virtually unchanged at 14.0 kcal mol−1. One may speculate
that the protonation state of Lys296 may be relevant for the
oxidative half-reaction, what is in accordance with the conclusion
for mouse polyamine oxidase (Henderson Pozzi and Fitzpatrick,
2010).
Following the same methodology, we also addressed
the catalytic step of MAO A catalyzed decomposition of
noradrenaline (Poberžnik et al., unpublished data). We showed
that MAO A lowers the activation barrier by 14.3 kcal mol−1
relative to the same reaction in aqueous solution. Taking
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FIGURE 6 | Structure of the MAO B active site with the reactive neutral
dopamine. The FAD prosthetic group is shown in orange, dopamine in light
blue, and Lys296 in violet.
into account the deprotonation of noradrenaline prior to the
hydride transfer reaction, the activation barrier in the enzyme is
calculated to be 20.3 ± 1.6 kcal mol−1, being in reasonably good
agreement with the correlated experimental value of 16.3 kcal
mol−1 (O’Carroll et al., 1986). The results presented here offer a
strong support that both MAO A and MAO B isoforms function
by the same hydride transfer mechanism.
In this study we also calculated the effects of point mutations
on the activation free energy. The choice of investigated systems
was prompted by the experimental work of Edmondson and co-
workers (Husain et al., 1982; Li et al., 2006). Our results show
that the pKa uncorrected values for the activation free energies
are as follows (in kcal mol−1): WT MAO A 18.7, Tyr444Phe
18.2, Tyr444Leu 19.3, Tyr444Trp, and Tyr444His 25.7. For the
last mutant, it is essential that His444 is neutral, otherwise
in monoprotonated His444 the barrier raises for additional
5 kcal mol−1. Taken all together, our analysis confirmed the
functional importance of the probed tyrosine residue, since
mutations to Leu, Trp, and His produced enzymes which are
less efficient, culminating with the Tyr444His mutant that is five
orders of magnitude a slower enzyme than WT. Interestingly,
Tyr444Phe mutation even slightly lowered the activation free-
energy, which strongly suggests that the role of the probed
Tyr44 residue is predominantly exerted through its aromatic
moiety, rather than through the hydroxyl –OH group, which
is a significant observation. It follows that the efficiency of the
wild-type MAO A enzyme and its Tyr444 mutants is WT =
Tyr444Phe > Tyr444Leu > Tyr444Trp > Tyr444His, and it
could be qualitatively related to the mentioned experimental
results in MAO B (Husain et al., 1982; Li et al., 2006), which
read WT > Tyr444Phe > Tyr444His≈Tyr444Leu > Tyr444Trp.
Another very interesting aspect is provided with His and Glu
mutants regarding their protonation forms. It turns out that
Tyr444His(0) mutant, where His residue is neutral, gives an
enzyme with 7 kcal mol−1 higher activation free-energy than
WT, which is even further increased by another 9 kcal mol−1
to 1G‡ = 34.9 kcal mol−1 in Tyr444His(+) upon protonating
the histidine residue, thus even exceeding the value for the
aqueous solution. This observation is consistent with the idea of
a positive charge build-up on the substrate in the transition state,
thus strongly confirming the anionic nature of the abstracted
hydride H−. Therefore, positively charged species near the
active site have an anti-catalytic effect as clearly indicated by
our results. To further test this concept, we investigated two
additional Tyr444Glu mutants corresponding to unionized and
negatively charged glutamic acid residues. For the neutral form,
Tyr444Glu(0), the barrier is higher than for the WT, assuming
1G‡ = 23.8 kcal mol−1, but is significantly reduced to 1G‡
= 21.7 kcal mol−1, when Glu residue is deprotonated to –
CH2–CH2–COO−. The induced negative charge in this active
site residue stabilizes the cationic transition state, which lowers
the barrier. Taken all together, the results obtained for both
Tyr444His and Tyr444Glu mutants and their protonation forms
provide a straightforward confirmation that MAO enzymes
operate through the hydride transfer mechanism (Poberžnik et
al., unpublished data).
HOW IMPORTANT IS NUCLEAR
TUNNELING FOR THE MAO CATALYTIC
STEP?
The rate limiting step of MAO catalyzed reaction involves a
hydride transfer and, as a light particle, its motion obeys the
laws of quantum mechanics rather than the laws of classical
mechanics. Nuclear quantum effect contributes to enzyme
kinetics by vibrational zero point energy that elevates the reactant
well and by tunneling through the barrier. Both effects have no
classical analog and often they are refereed in the literature as
“tunneling.” Both contributions give rise to the effective lowering
of the barrier reflected in enlarged rate constant. Since nuclear
quantum effects are mass dependent they are therefore different
for H and D.
Experimentally the quantum-mechanical nature of nuclei
motion in the reaction process is reflected as kinetic isotope effect
(KIE) that is, by definition, the ratio of the rate constants for
the species involving various isotopomers. The most pronounced
are always the KIE values involving H/D isotopes, because of
the large relative mass ratio of the isotopomers. Tunneling
reflected in H/D KIE for MAO catalyzed reactions was addressed
by several experimental studies. Husain et al. (1982) studied
bovine liver MAO B catalyzed decomposition of benzylamine.
The kinetic parameters were deduced from UV/VIS detection
of an aldehyde signal as a function of time at 25◦C. The H/D
KIE was dependent on the oxygen level. For the oxygen and
benzylamine saturation case the observed H/D KIE was 6.4–6.7,
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while at low oxygen levels the value increased to 8.7. In a detailed
study of Walker and Edmondson (Walker and Edmondson,
1994) the authors applied advanced data processing techniques
to address a series of para and meta substituted benzylamine
analogs. The H/D KIE value for unsubstituted benzylamine
was between 8.2 and 10.1, depending on the level of oxygen.
For the other substituted benzylamine species the H/D KIE
values were between 6.5 for p-Br substitution and 14.1 for m-
Cl substitution. Tunneling in recombinant human liver MAO A
catalyzed decomposition of para-substituted benzylamines was
studied by Miller and Edmondson (1999a) and the reported
values range between 6 and 13. Scrutton and co-workers studied
pH dependence of KIE in recombinant human liver MAO A
catalyzed decomposition of benzylamine and the value decreases
from ∼13 to 8 with increasing pH value (Dunn et al., 2008).
Wang and Edmondson addressed tunneling in a rat MAO
A for a series of p-substituted benzylamines (Walker and
Edmondson, 1994; Wang and Edmondson, 2011), concluding
that H/D KIE values are pH–independent and range from 7 to
14, demonstrating a rate-limiting α–CH bond cleavage step in
catalysis.
Interesting proposals were given for the role of tunneling
and dynamical effects in enzyme catalysis. These proposals were
mainly based on experimental detection and careful quantization
of hydrogen (radical, proton, and hydride) tunneling in
enzymatic reactions. Several independent groups gathered
evidence that room temperature nuclear tunneling occurs in
several enzymatic reaction, especially those involving C–H bond
activation (Hay et al., 2009; Klinman, 2009, 2013; Klinman and
Kohen, 2013). The donor-acceptor distance played a special
role in these proposals on which depends the shape of the
potential for hydrogen transfer. It was long ago proposed
that steric strain and compression can help catalysis (Jencks,
1987). The rationale behind assigning special relevance for
catalysis to the modes involving donor-acceptor distance is
that the authors suggest that for the compressed case the
barrier for hydrogen transfer just gets narrower at the preserved
height, which is a prerequisite for tunneling. The experimental
results were interpreted by the vibronic formula approach
(Klinman, 2013; Klinman and Kohen, 2013) and by a theory of
electron transfer-coupled hydrogen transfer (Hammes-Schiffer,
2010). In particular, recent studies argued that the promoting
mode proposal is consistent with pressure effects on enzymatic
reactions, and that the observed pressure effects support the
idea of vibrationally enhanced catalysis. By critical recompilation
of the experimental and multiscale simulation data we have
demonstrated that serious inconsistencies exist in the evidence
to support these hypotheses (Kamerlin et al., 2010). Tunneling
reflected in H/D KIE decreases upon compression, and external
pressure does not lead to the applicable compression of the
free energy surface. Moreover, pressure experiments do not
provide actual evidence for vibrationally enhanced catalysis (Hay
et al., 2007). Finally, the temperature dependence of the entropy
change in hydrogen transfer reactions is shown to reflect simple
electrostatic effects (Liu and Warshel, 2007). Hydrogen transfer
reactions in enzymology can be explained by the transition state
theory and the concept of promoting modes is not necessary. It is
enough to know the probability density for the reactive system
at the transition state and at the equilibrium. Speaking about
the computational methods to calculate the KIE, the method
of choice is path integration, where each quantum atoms is
represented by a necklace of beads. The method yields correct
ensemble averages and probability densities are different for H
and D giving rise to different activation free energies. Tunneling
is not a dynamical phenomenon and technically speaking KIE
can be calculated also by Monte Carlo method.
In this section we report the results of the path integration
calculated H/D KIE of the rate-limiting step of dopamine
decomposition catalyzed by MAO B (Mavri et al., 2016). We
would like to reiterate that the experimental data for dopamine
are not available, but for structurally closely related substituted
benzylamines and MAO B the values are between 6.5 and
14.1 indicating sensitivity of tunneling to all atomic details of
the reactive system. We decided to proceed with dopamine,
because of its immense importance in neuroscience and because
we have developed simulation protocol for this reaction for
classical treatment of nuclear motion (Repic´ et al., 2014b). In our
study, we considered the full dimensionality of the enzyme. Path
integration was implemented in the form of quantum classical
path (QCP) method with an EVB potential energy surface. We
obtained classical EVB reaction profile of the reacting system and
its surrounding protein with water molecules by the procedure
described above. TheQCP approach is based on the isomorphism
between the nuclear wavefunction involving all the vibrational
levels and the ring of quasiparticles. As the temperatures are
approaching zero, the quantum correction to free energy reduces
to the contribution of the zeroth vibrational level andmatches the
zero point energy. At the finite temperature values contribution
from all the excited states are included. Please note that the
harmonic force constants connection quasiparticles are larger for
D than for H and the H necklace is, therefore, more delocalized.
In order to evaluate the QCP correction to the activation free
energy, it is necessary to perform simulation for the transition
state and the reactant minimum. Both simulations are performed
for H and D, respectively. Since the wave function is more
delocalized for hydrogen than for deuterium, the corresponding
probability densities and therewith associated free energy values
are different. The procedure was as follows. Initially, we used
exactly the same protocol as for calculation of the reaction profile
with the classical treatment of nuclear motion. Equilibration
of 600 ps proved to be sufficient and was performed for the
system constrained with reaction coordinate corresponding to
the reactant well and to the transition state.We quantized nuclear
motion for the dopamine methylene group next to the amino
group and the N5 atom of the flavinmoiety using 18 beads. In this
way, themotion of four atoms was quantized corresponding to 12
degrees of freedom. 100 ps of QCP simulations followed for both
H and D. When performing calculations for the D isotopomer,
both hydrogen atoms of the methylene group were replaced by D
in order to facilitate comparison with the experiment. The error
was estimated by using 8 different starting points that were 1 ps
apart. Our computational strategy evaluated the relevant nuclear
quantum corrections and gave the observed kinetic isotope effect
of 12.8± 0.3 what is in agreement with the available experimental
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values in the range 6.5–14.1 for MAO B catalyzed decomposition
of substituted benzylamines. The latter represent structurally the
closest analogs of dopamine for which H/D KIE was determined.
The calculated H/D KIE gives additional piece of evidence that
the proposed hydride mechanism is valid. The H/D KIE values
for the enzymes where the contribution to the rate constant
comes only from the zero point energy of the reactant well are
between 3 and 8. The elevated value for MAO B indicates that
non-negligible contribution comes from tunneling through the
barrier in the reaction coordinate region around the transition
state. The calculated H/D KIE can be compared with the
work of Kästner and co-workers for benzylamine decomposition
catalyzed by MAO B (Zenn et al., 2015), who calculated H/D
KIE by diagonalizing mass weighted Hessian for reactant well
and transition state, respectively, by considering DFT described
reactive QM part of the system. Zero point energy corrections
were calculated for both isotopomers. The “through the barriers”
contribution to tunneling was calculated by one-dimensional
Eckart model allowing for the analytical solution. For the lowest
barrier conformation the authors obtained a H/D KIE value of
3.5, while for three others conformations the values 2.4, 2.7, and
3.7 were reported. We feel that these H/D KIE values cluster
around the lower limit, since they do not include anharmonicities
of all other vibrational modes but the CH stretching.
Our calculations once more demonstrated that the applied
rigorous QCP approach is a reliable computational tool and
it allows for quantum mechanical contributions to activation
free energies even in the case when significant tunneling
contributions to the rate constant are present. It is worth to
comment about the meaning of the H/D kinetic isotope effect
for the catalytic decomposition of dopamine. The fact is that
H isotopomer is decomposed over twelve times faster than the
corresponding D isotopomer. Since very much the same effect
is expected in the corresponding reaction in aqueous solution
the contribution to catalytic effect is highly probable expected to
be zero. This phenomenon was observed for lypoxygenase with
a spectacular H/D KIE of 81. It remains a challenge to perform
the isotope resolved kinetic experiments for the reaction between
dopamine and lumiflavin in aqueous solution. Because of very
low reaction rate this is a very demanding task.
Studies of H/D KIE have, beside insight to the enzyme
mechanism, relevance in the field of deuterated drugs. For drug
design and pharmacokinetics H/D KIE are highly relevant in
the context of advent of D substituted drug D isotopomers
(Katsnelson, 2013). In the present case treatment of patients with
deuterated L-dopa would result in a prolonged clearance time.
MAO, REACTIVE OXYGEN SPECIES, AND
NEURODEGENERATION
Neurodegenerative diseases aremainly caused by oxidative stress.
Among other sources, MAO catalyzed oxidative deamination
reactions produce hydrogen peroxide as a by-product giving rise
to several reactive oxygen species (ROS) that are responsible for
oxidative stress. For example, H2O2 molecules easily undergo
Fenton-type chemistry to give OH• radicals. A gross scheme
of neurodegeneration on the molecular level is based on two
pathways. Firstly, reactive species oxidize heavy atom ions,
which enhances the interaction with α–synuclein (αSyn), thus
promoting its folding to the beta form and giving rise to
insoluble amyloid plaques. The latter prevents the function of
vesicular transport leading to gradual neuronal death. In the
second pathway, radical species, OH• in particular, react with
the methylene groups of the apolar part of the lipid bilayer of
either the cell or mitochondrial wall, resulting in membrane
leakage followed by dyshomeostasis, loss of resting potential
and neuron death. Inflammation that follows is additional rich
source of ROS. Epidemiological data show that the incidence
of neurodegenerative diseases rapidly increases with the age.
MAO inhibition is an important strategy for the prevention and
treatment of neurodegenerative diseases. MAO is not the only
source of ROS, electron transfer (ET) chain is even a richer
source. It is worth to stress that ET cannot be inhibited, while
MAO inhibition is possible. ROS originating from inflammation
can be avoided to significant extents by COX–2 inhibition. In this
section we will give an overview of the processes associated with
these reactions that can be employed in developing strategies for
the prevention and treatment of neurodegeneration. For a very
recent review the reader should refer to reference (Pavlin et al.,
2016).
The central nervous system (CNS) is vulnerable to oxidative
stress and neurodegeneration is its direct consequence. An
important reason why central nervous system is so prone to
oxidative stress is that human brain consumes about 10 times
more oxygen than is the average over all other tissues, which is
directly linked to the high-energy consumption of neural signal
transduction. Human brain represents about 2% of the body
weight and consumes 20% of the oxygen. In addition, neurons
have large surface to volume ratio and therefore there is higher
probability for the cellular membrane damage than for other
cells. In contrast to other cells, neurons are non-replicating
and the brain is, despite massive redundancy, sensitive to the
loss of function if too many neurons die. Neurodegeneration
is a very complex pathological process. We are still very far
from understanding all the details, particularly on a molecular
level. Nevertheless, ROS, arising from several sources, including
the non-enzymatic oxidation of dopamine, electron transfer
chain, molecular oxygen, MAO catalyzed metabolism of biogenic
and dietary amines, and inflammatory processes, are largely
responsible for the damage to neurons. Additional complication
is that initial damage of neurons triggers inflammatory process
response that produces even more ROS resulting in perpetual
damages of the neurons. ROS can harm the membranes of either
neurons or mitochondria, thus inducing spillage of the contents,
depolarization and loss of function, followed by fast neuronal
death. Possibly more important than the toxic mechanism of
ROS, is the heavy metal ion mediated one, in which the metal
ions, especially copper and iron are oxidized, enhancing their
binding to αSyn that then folds to a significantly less soluble beta
form, which further aggregates into amyloid plaques. Keeping
reasonably low levels of ROS is essential for homeostasis, while
complete removal of ROS would have deleterious effect on
the immune system. Glutathione (GSH), present at milimolar
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concentrations inmost cell types, is amajor intracellular reducing
agent owing to its cysteine thiol group. Heavy metal ions
form stable complexes with GSH, thus significantly decreasing
its scavenging potential, and are involved in the Fenton and
Haber–Weiss reactions producing OH•. On the other hand,
H2O2 production from the non-enzymatic metal ions mediated
oxidative deamination of dopamine and noradrenaline seems
to be particularly problematic, since it is not restricted to the
mitochondrial membrane, where H2O2 decomposing enzymes,
such as catalase and glutathione peroxidase are located in
significant quantities. These are possible explanations for the
involvement of dopaminergic neurons in the initial stages of
Parkinson’s disease, while, at the same time, the loss of olfactory
neurons, which are mainly glutaminergic, gives strong evidence
for the essential role of either the electron transfer chain or
inflammatory processes in neurodegeneration.
There are many dietary components that can not only
scavenge ROS but also influence some of the biochemical events
(signal transduction, stress protein synthesis, glycation, and
toxin generation) associated with neurodegenerative pathologies,
thereby either ameliorating the risks or slowing down the
progression of the disease. In general, food containing sulfur
rich compounds, such as garlic, onion, and avocados, are
also good options. Bilirubin is a very efficient ROS scavenger
(Joshi et al., 1995), which provides a possible explanation
for a low incidence of cardiovascular diseases and, to a
certain extent, neurodegeneration in patients with Gilbert–
Meulengracht syndrome. A promising strategy for the prevention
and, to a certain extent, treatment of neurodegeneration is
the administration of curcumin, an essential ingredient of
curry, which has recently been demonstrated to have significant
neuroprotective potential (Trujillo et al., 2014). Interestingly, the
prevalence of Alzheimer’s disease in India among adults aged
between 70 and 79 years is 4.4 times lower than in the USA
(Mishra and Palanivelu, 2008). Green tea and coffee drinking
seems to have neuroprotective potential. Catechins found in
green tea can penetrate the hematoencephalic barrier and they
act as metal chelating agents and ROS scavengers.
The ROS production originating from inflammatory processes
in the central neural system can be blocked at the level of the
arachidonic acid cascade with one of the COX–2 selective non-
steroidal anti-inflammatory drugs (NSAID). Ibuprofen seems to
be a first-choice, because of its low ulceration potential (Gao et al.,
2011). However, it remains a challenge to balance the benefit of
NSAID administration with its unwanted side effects and to give
recommendations for administering NSAID in the context of
neuroprotection. It is probably not recommendable to administer
NSAID to patients with no signs of neurodegenerative diseases,
particularly as long-term therapies.
One can lower ROS production through the MAO pathway
by inhibiting MAO with one of the irreversible MAO B
inhibitors, such as selegiline and rasagiline. We suggested
chemical mechanism of the inhibition reaction (Borštnar et al.,
2011). MAO A inhibitors, such as clorgyline, seem to be less
appropriate because of their psychoactive properties (Pavlin
et al., 2013). An unknown substance(s) in tobacco smoke also
irreversibly inhibit MAO by up to 60%, suggesting that sporadic
smoking in low quantities, e.g., one cigar per week, could
be beneficial for the prevention of neurodegeneration (Fowler
et al., 1996), while balancing its potential in the development
of neoplasia and cardiovascular diseases. Interestingly, nicotine
per se is a reversible inhibitor of MAO (Pavlin and Sket, 1993),
while its metabolite nornicotine binds to the arginine side chain
in αSyn, thus preventing conformational change to its β–form
(Dickerson and Janda, 2003). Novel, promising strategies for
design of drugs used in treatment of neurodegeneration are
appearing. An interesting strategy is development of multi-
target drugs possessing both cholinesterase and MAO-inhibitory
activity like Ladostygil (Weinstock et al., 2000).
We have presented a few known chemical mechanisms
of neurodegeneration on the molecular level. One can view
neurodegeneration as the interplay of several chemical reactions
with complex kinetics. It is still plenty of work ahead to
get insight into the features of molecular events linked to
neurodegeneration, paving the way toward new strategies for the
prevention of and protection from these debilitating diseases.
CONCLUSION AND PERSPECTIVES
In this article, an overview of computational methods relevant for
molecular modeling of the processes relevant for central nervous
system was given with a focus on simulations of enzymes,
receptors, transporters, and reactions relevant for central nervous
system. We reviewed our work concerning monomine oxidases,
enzymes that catalyze the oxidative deamination of biogenic
neurotransmitters and cardio- and vasoactive amines. We
demonstrated by using quantum chemical methods on the cluster
model level that the rate-limiting first step for monoamine
oxidases represents a hydride transfer from the methylene group
next to the amino moiety to the flavin N5 atom. This is followed
by the substrate amino group deprotonation to the flavin N1
site, which creates a fully reduced flavin, FADH2, and neutral
imine. Comparison between the structure and pKa values of the
ionisable groups of the active centers of MAO A and MAO B
enzymes gives strong evidence that both enzymes operate by the
same chemical mechanism. By using the empirical valence bond
QM/MM approach, we showed that MAO B lowers the barrier
of the hydride transfer reaction by 12.3 kcal mol−1 relative to the
reference reaction in aqueous solution, corresponding to a rate-
enhancement of more than 9 orders of magnitude. The barrier for
the enzymatic reaction starting from the deprotonated substrate
is 14.2 kcal mol−1. Taking into account the free energy cost of
dopamine deprotonation in the active site prior to the enzymatic
reaction, the reaction barrier becomes 16.1 kcal mol−1, being
in excellent agreement with the available experimental value of
16.5 kcal mol−1. Assuming hydride transfer, we calculated H/D
kinetic isotope effect for MAO B catalyzed decomposition of
dopamine that is also in agreement with the experimental value.
In conjunction with additional experimental and computational
work, the data presented here improve the understanding of
the mechanism of the catalytic activity of MAO, as well as a
large family of flavoenzymes, which can allow for the design of
novel and improved MAO B inhibitors for antiparkinsonian and
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neuroprotective use. Understanding and treating depression on
the level of MAO A polymorphism and serotonin transporter
(SERT) polymorphism is a challenge for future. Very recently
published structure of SERT (Coleman et al., 2016), along with
the experimental genomic data and molecular simulation of
mutants represents a step forward toward the precisionmedicine.
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